Related Experiment Video
Updated: May 13, 2026
06:55
Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Estimation using all available covariate information versus a fixed look-back window for dichotomous covariates
Steven M Brunelli1, Joshua J Gagne, Krista F Huybrechts
1Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02120, USA. sbrunelli@partners.org
Pharmacoepidemiology and Drug Safety
|March 26, 2013
Summary
Using all available historical data to define covariates (C) in claims data analysis leads to less biased estimates compared to using a fixed window. This approach improves accuracy in risk ratio estimation.
Area of Science:
- Health Informatics
- Biostatistics
- Epidemiology
Background:
- Claims data analysis often assumes covariates (C) are absent unless a claim is observed.
- Investigators face a choice between using all historical data or a fixed window to assess C when historical data varies.
- This decision impacts the accuracy of estimating associations.
Purpose of the Study:
- To compare estimation methods for dichotomous covariates (C) using claims data.
- To evaluate the impact of using all available historical data versus a fixed window for defining C.
- To assess bias and accuracy in risk ratio estimation under different covariate definition paradigms.
Main Methods:
- Simulated cohorts of 20,000 subjects with dichotomous exposure (E), outcome (D), and time-invariant C.
- Operationally defined C under both 'all-available' and 'fixed-window' approaches.
- Estimated adjusted risk ratio of E on D using Mantel-Haenszel methods.
Main Results:
- The 'all-available' data approach demonstrated less bias and lower mean square error than the 'fixed-window' approach in base scenarios.
- Bias and error differences increased with higher modeled confounder strength.
- The 'all-available' approach remained less biased even with unmeasured covariates, better approximating true C values.
Conclusions:
- Operationally defining time-invariant dichotomous covariates using all available historical data generally yields less biased estimates.
- This method is preferable to using a commonly shared fixed historical window for claims data analysis.
- Improved covariate definition enhances the reliability of epidemiological estimates.
Related Concept Videos
01:19Survival Tree
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
Building a Survival Tree
Constructing a survival tree begins...
Building a Survival Tree
Constructing a survival tree begins...
01:20Comparing the Survival Analysis of Two or More Groups
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
01:24One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
On...
01:24Kaplan-Meier Approach
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
01:12Analysis of Population Pharmacokinetic Data
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
01:09Censoring Survival Data
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different reasons...